1.
Emerg Infect Dis
; 29(1): 226-228, 2023 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36573643
RESUMO
During November-December 2021, we performed a SARS-CoV-2 seroprevalence survey in Central and Western Divisions of Fiji. A total of 539 participants 8-70 years of age were 95.5% (95% CI 93.4%-97.1%) seropositive, indicating high community levels of immunity. Seroprevalence studies can inform public health responses to emerging SARS-CoV-2 variants.